# Aurobindo Pharma USA Inc – FDA Inspection, May 15, 2024

Source: https://www.keypedia.com/records/fda_inspections/aurobindo-pharma-usa-inc/653906f9-7952-4bff-9baa-c6b093dcc401
Source feed: FDA_Inspections

> FDA inspection 1238442 of Aurobindo Pharma USA Inc, May 15, 2024. Classification: Official Action Indicated (OAI). 2 citations. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1238442
- Company Name: Aurobindo Pharma USA Inc
- Inspection Date: 2024-05-15
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1316082 - 2026-06-04
- FDA Inspection 908515 - 2014-12-12
- FDA Inspection 783745 - 2012-05-30
- [FDA Inspection 736360 - 2011-07-29](https://www.keypedia.com/records/fda_inspections/aurobindo-pharma-usa-inc/bacfcc10-9940-4b19-9084-4bb60639c9f3)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/samir-c-gala/904c34ee-013d-4663-a87a-9cbdbcf2b40e)

Company: https://www.keypedia.com/companies/aurobindo-pharma-usa-inc/a8dbf5ca-1af1-432a-85b6-5a0c7499eaa5

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
